Literature DB >> 28138620

Cholangiocarcinoma: from risk to prevention?

Giovanni Brandi1, Stefania De Lorenzo2, Francesco Tovoli3.   

Abstract

Entities:  

Year:  2016        PMID： 28138620      PMCID： PMC5244746          DOI： 10.21037/tgh.2016.06.02

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  15 in total

Review 1.  Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies.

Authors:  A E Sirica; G H Lai; Z Zhang
Journal:  J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 4.029

2.  Aspirin use and risk of biliary tract cancer: a population-based study in Shanghai, China.

Authors:  Enju Liu; Lori C Sakoda; Yu-Tang Gao; Asif Rashid; Ming-Chang Shen; Bing-Sheng Wang; Jie Deng; Tian-Quan Han; Bai-He Zhang; Joseph F Fraumeni; Ann W Hsing
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-05       Impact factor: 4.254

Review 3.  Advances in the treatment of metastatic or unresectable biliary tract cancer.

Authors:  J W Valle
Journal:  Ann Oncol       Date:  2010-10       Impact factor: 32.976

Review 4.  Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

Authors:  György Baffy; Elizabeth M Brunt; Stephen H Caldwell
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

5.  Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: evidence from an animal model and a human cohort.

Authors:  Cleo Robinson; Helman Alfonso; Samantha Woo; Nola Olsen; A W Bill Musk; Bruce W S Robinson; Anna K Nowak; Richard A Lake
Journal:  Lung Cancer       Date:  2014-08-18       Impact factor: 5.705

6.  Aspirin dose and duration of use and risk of colorectal cancer in men.

Authors:  Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Eva S Schernhammer; Kana Wu; Charles S Fuchs
Journal:  Gastroenterology       Date:  2007-09-26       Impact factor: 22.682

Review 7.  Aspirin, salicylates, and cancer.

Authors:  Peter C Elwood; Alison M Gallagher; Garry G Duthie; Luis A J Mur; Gareth Morgan
Journal:  Lancet       Date:  2009-03-26       Impact factor: 79.321

8.  Aspirin may prevent cholangiocarcinoma: a case-control study from the United kingdom.

Authors:  N E Burr; R J Talboys; S Savva; A Clark; M Phillips; M Metcalfe; A Dennison; R Robinson; M P Lewis; M Rhodes; S Rushbrook; A R Hart
Journal:  Dig Dis Sci       Date:  2014-02-18       Impact factor: 3.199

Review 9.  Palliation of hepatic tumors.

Authors:  Steven C Cunningham; Michael A Choti; Emily C Bellavance; Timothy M Pawlik
Journal:  Surg Oncol       Date:  2007-11-01       Impact factor: 3.279

10.  Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case-control analysis.

Authors:  Giovanni Brandi; Stefania Di Girolamo; Andrea Farioli; Francesco de Rosa; Stefania Curti; Antonio Daniele Pinna; Giorgio Ercolani; Francesco Saverio Violante; Guido Biasco; Stefano Mattioli
Journal:  Cancer Causes Control       Date:  2013-02-14       Impact factor: 2.506
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.